研究文章

揭示了Affymetrix DMET +平台独特ADME-Related变体在阿拉伯民族的分布

表2

non-CYP450变体的分布水平DMET +平台。

集团 类型 所有 加器分布
未被发现 < 0.01 > 0.01

转运蛋白 ABC转运蛋白 242年 108 (0.44) 33 (0.14) 101 (0.42)
溶质转运蛋白 322年 137 (0.42) 47 (0.15) 138 (0.43)
atp酶、铜2 +转运蛋白α肽 17 7 (0.41) 1 (0.06) 9 (0.53)

转移酶 Glucuronosyltransferases (ugt) 116年 58 (0.50) 11 (0.10) 47 (0.40)
Sulfotransferases 138年 45 (0.33) 18 (0.13) 75 (0.54)
谷胱甘肽S-transferase 88年 42 (0.48) 4 (0.04) 42 (0.48)
n -乙酰氨基葡萄糖转移酶 37 20 (0.54) 5 (0.13) 12 (0.32)
NNMT HNMT,其他人(COMT的垫子,硫代嘌呤甲基转移酶,QPRT, PNMT) 40 19日(0.48) 5 (0.12) 16 (0.40)

脱氢酶 抗利尿激素;aldh、XDHs G6PD 104年 54 (0.52) 7 (0.07) 43 (0.41)

单氧酶 AOX fmo,人物形象 92年 38 (0.41) 10 (0.11) 44 (0.48)

还原酶 VKORC1 HMGCRs,穷,CBR 43 16 (0.37) 7 (0.16) 20 (0.47)

受体 NR1,成员2和3 21 11 (0.52) 3 (0.14) 7 (0.33)
PPARγ、δ 53 13 (0.25) 2 (0.03) 38 (0.72)
核受体亚科3 12 5 (0.42) 5 (0.42) 2 (0.16)
其他(RALBP1 SPN, APOA RXRA, AHR, ARNT) 25 11 (0.44) 4 (0.16) 10 (0.40)

杂项 铝青铜、ARSA CA5P AKAP CDA, CES上,PTGIS, CCDC, CROT,抢断,FAAH, EPHX, DCK,彩球,TBXAS, TPSG, ORM, PGAP3,阿通,PPP1R9, PRSS53, RPL, TYMS 144年 71 (0.49) 21日(0.15) 52 (0.36)

ABC,腺苷结合盒转运蛋白;ALDH醛脱氢酶;抗利尿激素、酒精脱氢酶3班;铝青铜,白蛋白;ARSA arylsulfatase;AHR,芳基碳氢化合物受体;AKAP锚蛋白激酶;APOA、载脂蛋白受体亚型;AOX,替代氧化酶;CA5P碳酸酐酶; CBR, carbonyl reductase; CCDC, coiled-coil domain-containing protein; CDA, cytidine deaminase; CES, carboxylesterase; COMT, catechol-O-methyl transferase; CROT, peroxisomal carnitine O-octanoyltransferase; DCK, deoxycytidine kinase; EPHX, microsomal epoxide hydrolase; FAAH, fatty acid amide hydrolase; FMO, flavin-containing monooxygenase; G6PD, glucose 6-phosphate dehydrogenase; HNMT, histamine N-methyltransferase; MAO, monoamine oxidase; MAT, methionine adenosyl transferases; NNMT, nicotinamide N-methyltransferase; NR1, nucleic acid receptor, group 1; ORM, orosomucoid; PGAP3, post-GPI attachment to proteins 3; PON, serum paraoxonase/arylesterase; POR, cytochrome P450 reductase; PPAR, peroxisome proliferator-activated receptors; PNMT, phenylethanolamine N-methyltransferase; PTGIS, prostaglandin-I synthase; QPRT, quinolinate phosphoribosyltransferase; PPP1R9, protein phosphatase 1, regulatory subunit 9B; PRSS53; serine protease, 53; RALBP1, ralA binding protein 1; RPL, ribosomal protein-binding receptor; RXRA, retinoic acid receptor; SERPINA, serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin); SPG, spastic paraplegia; SPN, sialophorin receptor; TBXAS, thromboxane A synthase 1 (platelet); TYMS, thymidylate synthetase; TPMT, thiopurine S-methyltransferase; TPSG, tryptase; XDH, xanthine dehydrogenases.